Skip to main content

Table 1 Baseline characteristics of study cohort

From: Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

 

All HAE patients (N = 631)

Sex, n (%)

 Female

448 (71.0)

 Male

183 (29.0)

Age (years), mean (SD)

38.3 (15.3)

Age Distribution, n (%)

  <12 years (%)

17 (2.7)

 12 to <17 years (%)

27 (4.3)

 17 to <65 years (%)

565 (89.5)

  ≥65 years (%)

22 (3.5)

Geographic region of the US, n (%)

 East

171 (27.1)

 Midwest

167 (26.5)

 South

249 (39.5)

 West

44 (7.0)

Payer Type, n (%)

 Commercial

452 (71.6)

 Self-insured

160 (25.4)

 Medicaid

13 (2.1)

 Medicare Risk

2 (0.3)

 Othera

3 (0.5)

 Missing/unknown

1 (0.2)

Charlson Comorbidity Index, mean (SD)

0.35 (0.78)

  1. HAE hereditary angioedema, SD standard deviation
  2. aOther included 1 patient (0.2%) each with the following: Medicare Cost (supplemental), State Children’s Health Insurance Program, Rx Only